atect corporation (4241.T) Stock
atect corporation

Company profile
atect reported revenue of 3.20 billion JPY for fiscal year 2025, up 0.8% from fiscal year 2024. Its largest business segment, Sanitary Inspection Equipment Business, brought in 57% of segment revenue in fiscal year 2025; Japan was the largest region with 76%. Our analysis of its filings shows revenue growing from 2.96 billion JPY in fiscal year 2023 to 3.20 billion JPY in fiscal year 2025, 4.0% a year on average. atect reports about 125 full-time employees.
What stands out
- It returned to a profit in fiscal year 2025, 40.18 million JPY, after a net loss of 244.35 million JPY in fiscal year 2024.
- Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.
Figures from company filings; latest fiscal year ended March 31, 2025.
About atect corporation
atect corporation engages in the sanitation inspection equipment, powder injection molding (PIM), and semiconductor material businesses in Japan, South Korea, Taiwan, and internationally. The company develops, sells, and services inspection and sanitation management products, including disposable inspection equipment for bioproducts, foodstuffs, and medical supplies, as well as disposable petri dishes, test tubes, and other products under the Full-Steri brand; and provides support services to its customers in bacteria cultures and detection. It is also involved in the development and manufacture of protective products and parts, which include spacer tapes used for TAB and COF in information electronic equipment parts and mold spacer tapes for PAT. In addition, the company produces sintered products for machines, electronic parts, and green devices in various industries; PIM binders; feedstock materials; and PIM for use in automotive heat sink, camera, medical endoscope part, implant article, and other precision instruments. atect corporation was founded in 1959 and is headquartered in Higashiomi, Japan.
Largest shareholders
- Sanko Co., Ltd.33.12%
- Hiroyuki Sato3.079 %3.08%
- Katsuhiko Muraoka2.525 %2.52%
- Naomi Togasaki2.078 %2.08%
- Norio Kotaka1.832 %1.83%
Share of the company, as of September 25, 2026
Leadership
- Makoto Ohnishi — President & Chairman, 64
- Takeo Sugawara — Accounting & Finance Department
- Tsuyoshi Yokota — Operating Officer
- Atsushi Wada — Operating Officer
- Takaki Sugiyama — Senior Executive Officer & Director, 60
How much revenue does atect make?
atect reported 3.20 billion JPY in revenue for fiscal year 2025, up 0.8% from 3.18 billion JPY in fiscal year 2024.
What is atect's largest business segment?
Sanitary Inspection Equipment Business, with 1.84 billion JPY or 57% of segment revenue in fiscal year 2025. Next: Semiconductor Materials Segment (35%) and PIM Business (7%).
Where does atect make most of its revenue?
Japan: 76% of revenue by region in fiscal year 2025, followed by Korea (13%).
What companies are similar to atect?
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include JMS Co.,Ltd. (7702.T), Create Medic Co., Ltd. (5187.T), Cyfuse Biomedical K.k. (4892.T), PhoenixBio Co., Ltd. (6190.T).
Has atect made a profit in recent years?
Net income by fiscal year: FY2021, 75.19 million JPY; FY2022, 169.79 million JPY; FY2023, 158.97 million JPY; FY2024, a loss of 244.35 million JPY; FY2025, 40.18 million JPY. It reported a net loss in 1 of these 5 years.
How has atect's revenue changed over the last 5 fiscal years?
Revenue by fiscal year: FY2021, 2.86 billion JPY; FY2022, 3.09 billion JPY; FY2023, 2.96 billion JPY; FY2024, 3.18 billion JPY; FY2025, 3.20 billion JPY.
Company Information
Contact & Links
Data as of .
How to cite: DataPorium, “atect corporation (4241.T)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/4241.T